Eistetter; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eistetter; Klaus.The latest application filed is for "oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient".

Company Profile

0.10.15

Eistetter; Klaus - Constance N/A DE
Eistetter; Klaus - Konstanz DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Device for dosing and dry nebulization Grant 9,713,682 - Eistetter , et al. July 25, 2	2017-07-25
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Grant 9,468,598 - Dietrich , et al. October 18, 2	2016-10-18
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290178 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290179 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient App 20150290180 - Dietrich; Rango ; et al.	2015-10-15
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20140031396 - Dietrich; Rango ; et al.	2014-01-30
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20140031397 - Dietrich; Rango ; et al.	2014-01-30
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20130345265 - Dietrich; Rango ; et al.	2013-12-26
Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient App 20130131123 - DIETRICH; Rango ; et al.	2013-05-23
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient Grant 8,431,154 - Dietrich , et al. April 30, 2	2013-04-30
Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient App 20110251244 - Dietrich; Rango ; et al.	2011-10-13
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Grant 7,951,397 - Dietrich , et al. May 31, 2	2011-05-31
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20110060016 - Dietrich; Rango ; et al.	2011-03-10
Device for Dosing and Dry Nebulization App 20090211577 - Eistetter; Klaus ; et al.	2009-08-27
Use of Surfactant Preparations for the Treatment of Surgical Adhesions App 20090011978 - Hafner; Dietrich ; et al.	2009-01-08
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20060269600 - Dietrich; Rango ; et al.	2006-11-30
Use of ciclesonide for the treatment of inflammatory bowel diseases App 20060211668 - Abel; Florian ; et al.	2006-09-21
Compositions Grant 6,998,410 - Hafner , et al. February 14, 2	2006-02-14
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient App 20050159492 - Dietrich, Rango ; et al.	2005-07-21
Substituted oxiranecarboxylic acids, their preparation and their use as medicaments Grant 4,430,339 - Eistetter , et al. February 7, 1	1984-02-07
Anti-depressant and analgesic 4-phenoxypiperidines Grant 4,333,942 - Eistetter , et al. June 8, 1	1982-06-08
2-(Optionally-substituted)benzylperhydroazepines for analgesia and lowering blood pressure Grant 4,221,788 - Eistetter September 9, 1	1980-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.